Legislative Research: NY S04497 | 2019-2020 | General Assembly
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 General Assembly (Introduced) | Relates to the license requirements for the practice of respiratory therapy. [S04497 2023 Detail][S04497 2023 Text][S04497 2023 Comments] | 2024-01-03 REFERRED TO HIGHER EDUCATION |
| 2021-2022 General Assembly (Introduced - Dead) | Relates to the confinement of inmates under the age of eighteen who shall not be placed in segregated confinement for any reason. [S04497 2021 Detail][S04497 2021 Text][S04497 2021 Comments] | 2022-01-05 REFERRED TO CRIME VICTIMS, CRIME AND CORRECTION |
| 2019-2020 General Assembly (Passed) | Establishes the rare disease advisory council; advise and consult on policy matters relating to rare disease; twenty-one appointed members. [S04497 2019 Detail][S04497 2019 Text][S04497 2019 Comments] | 2019-12-20 approval memo.66 |
| 2017-2018 General Assembly (Introduced - Dead) | Extends provisions of law relating to establishing the New York telecommunications relay service center. [S04497 2017 Detail][S04497 2017 Text][S04497 2017 Comments] | 2017-05-24 SUBSTITUTED BY A6527A |
| 2015-2016 General Assembly (Introduced - Dead) | Relates to establishing a moratorium on unfunded mandates and creating regional mandate relief councils. [S04497 2015 Detail][S04497 2015 Text][S04497 2015 Comments] | 2016-01-06 REFERRED TO INVESTIGATIONS AND GOVERNMENT OPERATIONS |
| 2013-2014 General Assembly (Introduced - Dead) | Relates to audits by the state comptroller of certain organizations directly or indirectly controlled by municipal corporations and certain other government entities. [S04497 2013 Detail][S04497 2013 Text][S04497 2013 Comments] | 2014-06-20 COMMITTED TO RULES |
| 2011-2012 General Assembly (Introduced - Dead) | Enacts the "institutional investor recovery act"; relates to an action by certain public retirement systems or multi-employer health and welfare plans organized under the Taft-Hartley act. [S04497 2011 Detail][S04497 2011 Text][S04497 2011 Comments] | 2012-01-04 REFERRED TO CONSUMER PROTECTION |
| 2009-2010 General Assembly (Introduced - Dead) | Requires manufacturers of cigarettes sold or distributed in the state to disclose additives and product design characteristics used in the manufacture of cigarettes and to identify those substances and characteristics which have been determined to be... [S04497 2009 Detail][S04497 2009 Text][S04497 2009 Comments] | 2010-01-06 REFERRED TO HEALTH |
References Online
| Search Phrase | Web | News | Financial | Encylopedia | Biography |
|---|---|---|---|---|---|
| [New York S04497] | Google Web | Google News | |||
| [Senator Gustavo Rivera NY] | Google Web | Google News | FollowTheMoney | Ballotpedia | VoteSmart |
| [Senator Patrick Gallivan NY] | Google Web | Google News | FollowTheMoney | Ballotpedia | VoteSmart |
| [Senator Shelley Mayer NY] | Google Web | Google News | FollowTheMoney | Ballotpedia | VoteSmart |
| [Senator Kevin Parker NY] | Google Web | Google News | FollowTheMoney | Ballotpedia | VoteSmart |
| [Senator Toby Stavisky NY] | Google Web | Google News | FollowTheMoney | Ballotpedia | VoteSmart |
| [Senator Kevin Thomas NY] | Google Web | Google News | FollowTheMoney | Ballotpedia | VoteSmart |
Legislative Citation
APA
NY S04497 | 2019-2020 | General Assembly. (2019, December 20). LegiScan. Retrieved April 26, 2024, from https://legiscan.com/NY/bill/S04497/2019
MLA
"NY S04497 | 2019-2020 | General Assembly." LegiScan. LegiScan LLC, 20 Dec. 2019. Web. 26 Apr. 2024. <https://legiscan.com/NY/bill/S04497/2019>.
Chicago
"NY S04497 | 2019-2020 | General Assembly." December 20, 2019 LegiScan. Accessed April 26, 2024. https://legiscan.com/NY/bill/S04497/2019.
Turabian
LegiScan. NY S04497 | 2019-2020 | General Assembly. 20 December 2019. https://legiscan.com/NY/bill/S04497/2019 (accessed April 26, 2024).
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| A05762 | Same As | 2019-12-20 | Establishes the rare disease advisory council; advise and consult on policy matters relating to rare disease; twenty-one appointed members. | approval memo.66 |
